HistoSonics has 6 close competitors: Alloy Therapeutics, Neuralink, Zocdoc.
Sector, valuation and status for each competitor.
competitor›
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
NeuralinkZocdocAbridgeCommureHeartFlowHistoSonics - private company
HistoSonics competes with 6 companies here: Alloy Therapeutics, Neuralink, Zocdoc, Abridge, Commure, HeartFlow.
HistoSonics was last valued at $2.2B (Aug 2025). That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
The last valuation is $2.2B.
Lead investors for each round are in the funding timeline.
The closest medical device peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
